Investor Information

News

Summit Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

View News

Summit Therapeutics to Present at the 43rd Annual J.P. Morgan Healthcare Conference

View News

More Information

Share Price

NASDAQ: SMMT

19.03 USD

17-Jan-2025 16:00 UTC-5

More Information

SEC Filings

Statement of changes in beneficial ownership of securities

View News

Current report filing

View News

More Information

Email Alerts